Buyers Seek $97M Fees From $335M Drug Price-Fixing Deals
A class of direct purchaser plaintiffs in the multidistrict antitrust litigation over generic drug pricing asked a Pennsylvania federal judge Monday to award them $97 million in fees across six settlements...To view the full article, register now.
Already a subscriber? Click here to view full article